Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

Clinical trial NCT00506168 · TERMINATED

Trial details

NCT number: NCT00506168
Sponsor: National Cancer Center, Korea
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Neoplasms Secondary Drug Therapy, Combination

Start date: 2001-11-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.